🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Authors
Joseph R. Marszalek

Joseph R. Marszalek

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0003-2320-3209

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials”.

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials

Nature Medicine(2023)10.1038/s41591-022-02103-8

N/A

4.3DataRank · unranked

388 citations

Naval Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric‐Bernstam +44 more

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

Nature(2022)10.1038/s41586-022-04833-8

N/A

0.731DataRank · unranked

130 citations

Michael G. White, Miles C. Andrews, Manoj Chelvanambi, Russell G. Witt, Joseph R. Daniele +60 more

PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma

Nature Communications(2021)10.1038/s41467-021-24798-y

N/A

0.655DataRank · unranked

78 citations

Meredith A. Miller, Chiu-Yi Liu, Stella R. Hartono, Caleb A. Class, Christopher A. Bristow +33 more

Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia

Nature Communications(2022)10.1038/s41467-022-30396-3

N/A

0.624DataRank · unranked

63 citations

Alessia Lodi, Yogesh Dhungana, Shelley M. Herbrich, Meghan Collins, Shannon Sweeney +50 more

Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-1763

N/A

0.406DataRank · unranked

14 citations

Virginia Giuliani, Wei‐Lien Wang, Daniel J. McGrail, Christopher A. Bristow, Natalie Y.L. Ngoi +46 more

Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in Braf -mutated melanoma

OncoImmunology(2021)10.1080/2162402x.2021.1992880

N/A

0.385DataRank · unranked

12 citations

Robert Szczepaniak‐Sloane, Russell G. Witt, Alexandre Reuben, Pierre Olivier Gaudreau, Miles C. Andrews +27 more

Targeting Oxidative Phosphorylation with a Mitochondrial Complex I Inhibitor is limited by Mechanism-based Toxicity

Research Square(2022)10.21203/rs.3.rs-1506700/v1

N/A

0.269DataRank · unranked

5 citations

Timothy A. Yap, Naval Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka +43 more

Inhibition of Oxidative Phosphorylation Reverses Bone Marrow Hypoxia Visualized in Imageable Syngeneic B-ALL Mouse Model

Frontiers in Oncology(2020)10.3389/fonc.2020.00991

N/A

0DataRank · unranked

18 citations

Karine G. Harutyunyan, Natalia Baran, Saradhi Mallampati, Malgorzata Anna Zal, Antonio Cavazos +9 more

Subtype and Site Specific–Induced Metabolic Vulnerabilities in Prostate Cancer

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-22-0250

N/A

0DataRank · unranked

17 citations

Daniele Robesti, Sumankalai Ramachandran, Eva Corey, Mark Titus, Yuqi Kang +10 more

Feasibility of administering human pancreatic cancer chemotherapy in a spontaneous pancreatic cancer mouse model

BMC Cancer(2022)10.1186/s12885-022-09255-3

N/A

0DataRank · unranked

9 citations

Joseph Abi Jaoude, Morgan Green, Tara N. Fujimoto, Jessica M. Molkentine, Carolina J. García García +6 more

Androgen receptor activity promotes resistance to BRAF-targeted melanoma therapy

Research Square(2020)10.21203/rs.3.rs-58480/v1

N/A

0DataRank · unranked

0 citations

Christopher P. Vellano, Michael White, Miles C. Andrews, Joseph R. Daniele, Mark Titus +41 more

Pharmacologic profiling of patient-derived xenograft models of primary treatment-naïve triple-negative breast cancer

Scientific Reports(2020)10.1038/s41598-020-74882-4

N/A

0DataRank · unranked

22 citations

Abena B. Redwood, Xuan Liu, Lei Guo, Shirong Cai, Xinhui Zhou +19 more

Ether phospholipids are required for mitochondrial reactive oxygen species homeostasis

Nature Communications(2023)10.1038/s41467-023-37924-9

N/A

0DataRank · unranked

48 citations

I-Lin Ho, Melinda Soeung, Er-Yen Yen, Jintan Liu, Yan Liang +22 more

Comparative Pharmacology of a Bis-Pivaloyloxymethyl Phosphonate Prodrug Inhibitor of Enolase after Oral and Parenteral Administration

ACS Pharmacology & Translational Science(2023)10.1021/acsptsci.2c00216

N/A

0DataRank · unranked

6 citations

Yasaman Barekatain, Yu-Hsi Lin, Nikunj Satani, Naima Hammoudi, Kenisha Arthur +7 more

Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000289

N/A

0DataRank · unranked

97 citations

Hampartsoum B. Barsoumian, Grant M. Fischer, Liangpeng Yang, Vivek Verma, Ahmed Younes +9 more